Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Investors might want to bet on Olo Inc. (OLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Unity Bancorp (UNTY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 15th: BRF S.A ...

Enphase Energy (ENPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the closing of the recent trading day, Broadcom Inc. (AVGO) stood at $182.31, denoting a +0.46% change from the preceding ...

Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter ...

Orion previously completed a full LED retrofit across the client’s existing stores, which is a testament to the success of ...

The most recent trading session ended with Alibaba (BABA) standing at $107.89, reflecting a -1.63% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's daily ...